Post-Polypectomy Surveillance: Are We Over-Scoping Patients (and Under-Scoping the High-Risk Ones)? Review Key Takeaways Post polypectomy surveillance is a critical component of colorectal cancer prevention strategies, aimed at reducing the incidence of interval colorectal cancers through timely follow up colonoscopy after adenoma removal. However, current surveillance practices
Oncology
Thrombosis and Cancer Immunotherapy: The Next Frontier of Thromboinflammation
Thrombosis and Cancer Immunotherapy The Next Frontier of Thromboinflammation Review Abstract Cancer immunotherapy has fundamentally transformed the treatment landscape across multiple malignancies, offering durable responses and prolonged survival in patients with previously limited therapeutic options. Immune checkpoint inhibitors, chimeric antigen receptor T cell therapies, bispecific antibodies,
Skin of Color Dermatology: Why Current Medical Guidelines Are Leaving Patients Behind
Skin of Color Dermatology: Why Current Medical Guidelines Are Leaving Patients Behind Review Key Takeaways Contemporary dermatology practice continues to demonstrate significant limitations in the diagnosis and management of conditions in patients with darker skin tones, contributing to measurable disparities in clinical outcomes. As individuals
AI in the Endoscopy Suite: Adenoma Detection Booster or Expensive Distraction?
AI in the Endoscopy Suite Adenoma Detection Booster or Expensive Distraction Review Abstract Artificial intelligence systems designed for adenoma detection during colonoscopy represent a remarkable advancement in gastrointestinal endoscopy and colorectal cancer prevention. Colonoscopy remains the gold standard for colorectal cancer screening, yet its effectiveness is highly operator
CAR T Cell Therapy: The Truth About Off-the-Shelf Treatments in 2026
CAR T Cell Therapy The Truth About Off-the-Shelf Treatments in 2026 Review Key Takeaways Chimeric antigen receptor T cell therapy has transformed the treatment landscape for several hematologic malignancies, offering the potential for durable remission in patients with otherwise refractory disease. Conventional CAR T cell therapy relies on
The Microbiome as a Cancer Therapy Lever: Real Clinical Tool or Science Fair?
The Microbiome as a Cancer Therapy Lever: Real Clinical Tool or Science Fair? Abstract The human microbiome has emerged as a potential therapeutic target in oncology, generating considerable interest among researchers and clinicians. This analysis examines current evidence on microbiome-based cancer interventions, evaluating their clinical
AI in Hematopathology: How Digital Smears Enable Automated Blood Cell Classification
AI in Hematopathology: How Digital Smears Enable Automated Blood Cell Classification Key Takeaways AI-powered digital microscopy is revolutionizing blood cell analysis, achieving diagnostic accuracy rates up to 95% while dramatically reducing processing time and improving statistical reliability through massive cell analysis capabilities. AI achieves
Stool Testing vs Colonoscopy After a Positive FIT: How Fast Is Fast Enough?
Stool Testing vs Colonoscopy After a Positive FIT: How Fast Is Fast Enough? Abstract A positive fecal immunochemical test (FIT) represents a critical juncture in colorectal cancer screening, signaling the need for timely diagnostic evaluation to identify underlying neoplasia. Following a positive result, patients
The New Margin Wars in Oncology: Less Is More…Until It Isn’t
Thyroid Cancer Overdiagnosis: When Screening Causes More Harm Than Good
Thyroid Cancer Overdiagnosis When Screening Causes More Harm Than Good Abstract The incidence of thyroid cancer has risen substantially over the past three decades, drawing increased attention from clinicians, researchers, and public health authorities. Much of this rise has been attributed not to a true surge in aggressive
